NCNA ▲ +4.2% - NuCana plc
$NCNA - NuCana Presents Preclinical Data Showing NUC-7738 Enhances Carfilzomib Activity in Multiple Myeloma Cell Lines at the 38th EORTC-NCI-AACR Symposium
20-NOV-2026 08:00 AM ET
Share this post
More filings for $NCNA
NCNA ▼ -1.1% - NuCana plcNov 12, 2026NCNA ▲ +2.5% - NuCana plcSep 30, 2026NCNA ▼ -5.4% - NuCana plcAug 28, 2026NCNA ▼ -5.4% - NuCana plcAug 28, 2026
View full $NCNA filing history →💬 Comments
Loading comments…
Leave a comment
